1. Yin, Xiaofeng, Wu, Quansheng, Hao, Zheng, Chen, Laizhao. 2022. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. In Biomedical engineering online, 21, 26. doi:10.1186/s12938-022-00995-8. https://pubmed.ncbi.nlm.nih.gov/35436915/
2. Guo, Haiyang, Shu, Jinghao, Hu, Guangbing, Yin, Yaolin, Wang, Xianfei. 2024. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization. In PloS one, 19, e0302780. doi:10.1371/journal.pone.0302780. https://pubmed.ncbi.nlm.nih.gov/38713738/
3. Liu, Han, Guo, Haiyang, Wu, Yuehan, Zhao, Runzhe, Liu, Ying. 2023. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization. In Scientific reports, 13, 21488. doi:10.1038/s41598-023-48801-2. https://pubmed.ncbi.nlm.nih.gov/38057406/
4. Deng, Sisi, Pan, Yuming, An, Na, Du, Xin, Zhang, Qiaoxia. 2023. Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells. In Molecular oncology, 17, 2584-2602. doi:10.1002/1878-0261.13521. https://pubmed.ncbi.nlm.nih.gov/37746742/